Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Kristina Harper, Mary B. Short, Steven Bistricky & Isabelle S. Kusters. (2023) 1-2-3! Catch-Up for HPV: A Theoretically Informed Pilot Intervention to Increase HPV Vaccine Uptake among Young Adults. American Journal of Health Education 54:2, pages 119-134.
Read now
Read now
Robert A. Bednarczyk. (2019) Addressing HPV vaccine myths: practical information for healthcare providers. Human Vaccines & Immunotherapeutics 15:7-8, pages 1628-1638.
Read now
Read now
Fabio Barra, Umberto Leone Roberti Maggiore, Giorgio Bogani, Antonino Ditto, Mauro Signorelli, Fabio Martinelli, Valentina Chiappa, Domenica Lorusso, Francesco Raspagliesi & Simone Ferrero. (2019) New prophylactics human papilloma virus (HPV) vaccines against cervical cancer. Journal of Obstetrics and Gynaecology 39:1, pages 1-10.
Read now
Read now
Rosa De Vincenzo, Carmine Conte, Caterina Ricci, Giovanni Scambia & Giovanni Capelli. (2014) Long-term efficacy and safety of human papillomavirus vaccination. International Journal of Women's Health 6, pages 999-1010.
Read now
Read now
Vladimir Gilca, Chantal Sauvageau, Nicole Boulianne, Gaston De Serres, Michel Couillard, Mel Krajden, Manale Ouakki, Donald Murphy, Andrea Trevisan & Marc Dionne. (2014) Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9–10 year-old girls according to 0–6 month schedule. Human Vaccines & Immunotherapeutics 10:8, pages 2438-2445.
Read now
Read now
Paulo S Naud, Cecilia M Roteli-Martins, Newton S De Carvalho, Julio C Teixeira, Paola C de Borba, Nervo Sanchez, Toufik Zahaf, Gregory Catteau, Brecht Geeraerts & Dominique Descamps. (2014) Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine. Human Vaccines & Immunotherapeutics 10:8, pages 2147-2162.
Read now
Read now
Margaret A Stanley, Staci L Sudenga & Anna R Giuliano. (2014) Alternative dosage schedules with HPV virus-like particle vaccines. Expert Review of Vaccines 13:8, pages 1027-1038.
Read now
Read now
Fengcai Zhu, Juan Li, Yuemei Hu, Xiang Zhang, Xiaoping Yang, Hui Zhao, Junzhi Wang, Jianguo Yang, Guodong Xia, Qinyong Dai, Haiwen Tang, Pemmaraju V Suryakiran, Sanjoy K Datta, Dominique Descamps, Dan Bi & Frank Struyf. (2014) Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese girls and women aged 9 to 45 years. Human Vaccines & Immunotherapeutics 10:7, pages 1795-1806.
Read now
Read now
Barbara Romanowski, Tino F Schwarz, Linda M Ferguson, Murdo Ferguson, Klaus Peters, Marc Dionne, Karin Schulze, Brian Ramjattan, Peter Hillemanns, Ulrich Behre, Pemmaraju Suryakiran, Florence Thomas & Frank Struyf. (2014) Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination. Human Vaccines & Immunotherapeutics 10:5, pages 1155-1165.
Read now
Read now
Articles from other publishers (21)
Megumi Kurosawa, Masayuki Sekine, Manako Yamaguchi, Risa Kudo, Sharon J. B. Hanley, Megumi Hara, Sosuke Adachi, Yutaka Ueda, Etsuko Miyagi, Sayaka Ikeda, Asami Yagi & Takayuki Enomoto. (2022) Long-Term Effects of Human Papillomavirus Vaccination in Clinical Trials and Real-World Data: A Systematic Review. Vaccines 10:2, pages 256.
Crossref
Crossref
Hyun-Woong Cho, Kyung-Jin Min, Sang-Hoon Kwon, Kidong Kim, Sunghoon Kim, Seok Ju Seong, Yong Jung Song, Keun Ho Lee, Shin-Wha Lee, Jeong-Won Lee, Woong Ju, Young Tae Kim & Jae Kwan Lee. (2021) Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines. Journal of Gynecologic Oncology 32:6.
Crossref
Crossref
Vicky Gent, Rebecca Waihenya, Lucy Kamau, Ruth Nyakundi, Peris Ambala, Thomas Kariuki & Lucy Ochola. (2019) An investigation into the role of chronic Schistosoma mansoni infection on Human Papillomavirus (HPV) vaccine induced protective responses. PLOS Neglected Tropical Diseases 13:8, pages e0007704.
Crossref
Crossref
Marc Arbyn, Lan Xu, Cindy Simoens & Pierre PL Martin-Hirsch. (2018) Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database of Systematic Reviews 2020:3.
Crossref
Crossref
Lan Lin, Mercedes Macias Parra, Victor Y. Sierra, Albino Salas Cespedes, Maria Angelica Granados, Adriana Luque, Silvia Damaso, Maria Mercedes Castrejon Alba, Luis Romano-Mazzotti & Frank Struyf. (2018) Safety and Immunogenicity of the HPV-16/18 AS04-adjuvanted Vaccine in 4–6-year-old Girls. Pediatric Infectious Disease Journal 37:4, pages e93-e102.
Crossref
Crossref
Sabrina Piedimonte, Annie Leung, Andrew Zakhari, Céline Giordano, Pierre-Paul Tellier & Susie Lau. (2018) Impact of an HPV Education and Vaccination Campaign among Canadian University Students. Journal of Obstetrics and Gynaecology Canada 40:4, pages 440-446.
Crossref
Crossref
Kimberly R. McBride & Shipra Singh. (2017) Predictors of Adults’ Knowledge and Awareness of HPV, HPV-Associated Cancers, and the HPV Vaccine: Implications for Health Education. Health Education & Behavior 45:1, pages 68-76.
Crossref
Crossref
Kyung-Jin Min, Sang-Hoon Kwon, Sunghoon Kim, Hyun Jung KimSeok Ju SeongYong Jung Song, Jin Woo ShinKeun-Ho Lee, Myong Cheol Lim, Hyun Hoon Chung, Woong JuJin Hwa HongJeong-Won Lee, Jae-Weon Kim, Duk-Soo BaeJae-Kwan Lee. (2016) Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline. Journal of Gynecologic Oncology 27:3.
Crossref
Crossref
Rolando Herrero, Paula González & Lauri E Markowitz. (2015) Present status of human papillomavirus vaccine development and implementation. The Lancet Oncology 16:5, pages e206-e216.
Crossref
Crossref
João Carlos Magi. (2015) Reflections on the role of the vaccine against human papillomavirus (HPV) in Sexually Transmitted Diseases (STDs). Journal of Coloproctology 35:2, pages 137-138.
Crossref
Crossref
Amanda F. Dempsey, Sarah E. Brewer, Jennifer Pyrzanowski, Carter Sevick & Sean T. O’leary. (2015) Acceptability of human papillomavirus vaccines among women older than 26 years. Vaccine 33:13, pages 1556-1561.
Crossref
Crossref
T Schwarz, M Spaczynski, A Kaufmann, J Wysocki, A Gałaj, K Schulze, P Suryakiran, F Thomas & D Descamps. (2014)
Persistence of immune responses to the
HPV
‐16/18
AS
04‐adjuvanted vaccine in women aged 15–55 years and first‐time modelling of antibody responses in mature women: results from an open‐label 6–year follow‐up study
. BJOG: An International Journal of Obstetrics & Gynaecology 122:1, pages 107-118.
Crossref
Crossref
L. W. Gustafson, Melina Gade & Jan Blaakær. (2014) Vulval cancer and HPV vaccination in recurrent disease. Clinical Case Reports 2:6, pages 243-246.
Crossref
Crossref
Hanna Seitz & Martin Müller. (2014) Current perspectives on HPV vaccination: a focus on targeting the L2 protein. Future Virology 9:7, pages 633-653.
Crossref
Crossref
Maria‐Genalin Angelo, Marie‐Pierre David, Julia Zima, Laurence Baril, Gary Dubin, Felix Arellano & Frank Struyf. (2014) Pooled analysis of large and long‐term safety data from the human papillomavirus‐16/18‐AS04‐adjuvanted vaccine clinical trial programme. Pharmacoepidemiology and Drug Safety 23:5, pages 466-479.
Crossref
Crossref
Helen Beer, Sam Hibbitts, Sinead Brophy, M.A. Rahman, Jo Waller & Shantini Paranjothy. (2014) Does the HPV vaccination programme have implications for cervical screening programmes in the UK?. Vaccine 32:16, pages 1828-1833.
Crossref
Crossref
Kristine K. Macartney, Clayton Chiu, Melina Georgousakis & Julia M. L. Brotherton. (2013) Safety of Human Papillomavirus Vaccines: A Review. Drug Safety 36:6, pages 393-412.
Crossref
Crossref
Aureli Torné Bladé, José María Bayas Rodríguez, Xavier Castellsagué Piqué, María Castro Sánchez, Enrique García García, Juan Carlos Martínez Escoriza, Luis María Puig-Tintoré, Alfonso Quesada López-Fe & José Antonio Vidart Aragón. (2012) Vacunación frente al cáncer de cérvix en mujeres fuera de los programas de vacunación sistemática, con o sin infección por el virus del papiloma humano o lesión cervical. Encuesta de opinión y recomendaciones. Progresos de Obstetricia y Ginecología 55, pages 10-31.
Crossref
Crossref
Javier Cortés Bordoy. (2012) Vacunación frente al virus del papiloma humano. Documento de consenso 2011 de las sociedades científicas españolas. SEMERGEN - Medicina de Familia 38:5, pages 312-326.
Crossref
Crossref
Eduardo L FrancoTino F Schwarz. 2011. Human Papillomavirus Vaccines. Human Papillomavirus Vaccines
38
50
.
Diane M. Harper & Stephen L. Vierthaler. (2011) Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females. ISRN Obstetrics and Gynecology 2011, pages 1-20.
Crossref
Crossref